Genomic Vision

Genomic Vision Dividend

Dividend of Genomic Vision (GV.PA) as of Nov 10, 2026.

Dividend

0.00EUR

Last updated:

How much dividend does Genomic Vision 2026 pay?

According to the latest status from November 2026, Genomic Vision paid a total of 0.00 EUR per share in dividends within the last 12 months. With the current Genomic Vision price of 1,049.65 EUR, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Genomic Vision Dividends

Historical Genomic Vision Dividends
PaydateDividend

The Genomic Vision Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2015
0.00 EUR
Jan 1, 2016
0.00 EUR
Jan 1, 2017
0.00 EUR
Jan 1, 2018
0.00 EUR
Jan 1, 2019
0.00 EUR
Jan 1, 2020
0.00 EUR
Jan 1, 2021
0.00 EUR
Jan 1, 2022
0.00 EUR
The Genomic Vision Dividend history
YEARDividendYoY
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—

Is the Genomic Vision Dividend Safe?

Genomic Vision has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Genomic Vision's Dividend Distributions

Genomic Vision’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Genomic Vision's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Genomic Vision's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Genomic Vision’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Genomic Vision Stock analysis

What does Genomic Vision do? Genomic Vision is a biotechnology company that was founded in 2004. It is based in Bagneux, France, and develops and markets innovative molecular diagnostic tools and services based on its patented platform technology. The company's business model is based on collaboration with large pharmaceutical and diagnostic companies to help accelerate their product development and improve their clinical outcomes. Genomic Vision specializes in genetic diagnostics and offers a platform for analyzing DNA structures, allowing for the detection and quantification of genetic changes associated with various diseases such as cancer, neurological disorders, and rare diseases. The company also offers customized solutions and services tailored to the specific needs of its customers. In addition, Genomic Vision licenses its technology and patents to pharmaceutical companies and other organizations. The company has already partnered with Hitachi High-Technologies in Japan to market its platform for cancer monitoring and to develop molecular tests for cancer and other diseases. Genomic Vision has also introduced products such as the FiberVision system for visualizing and analyzing DNA fibers and is working on a new diagnostic test for precise diagnosis of autism and other neurological disorders. The company aims to improve the diagnosis of genetic diseases and advance genomic research. With its patented technology and expertise in molecular diagnostics, Genomic Vision is well positioned to drive the development of new and innovative products. Overall, Genomic Vision is an emerging company focused on the development of molecular diagnostic tools and services, and has a solid foundation in DNA visualization and analysis. With its innovative products and services, the company is well positioned to drive the growth of the molecular diagnostics market and establish itself as a key player in the field. Genomic Vision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomic Vision stock

Genomic Vision paid dividends every year for the past 0 years.

Genomic Vision is assigned to the 'Health' sector.

The dividends of Genomic Vision are distributed in EUR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Genomic Vision